These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 31036761)

  • 21. Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of α-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and function.
    Creed RB; Memon AA; Komaragiri SP; Barodia SK; Goldberg MS
    Acta Neuropathol Commun; 2022 May; 10(1):78. PubMed ID: 35606853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.
    Sorrentino ZA; Vijayaraghavan N; Gorion KM; Riffe CJ; Strang KH; Caldwell J; Giasson BI
    J Biol Chem; 2018 Dec; 293(49):18914-18932. PubMed ID: 30327435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of pSer129-αSyn Pathology and Neurofilament Light-Chain Release across In Vivo, Ex Vivo, and In Vitro Models of Pre-Formed-Fibril-Induced αSyn Aggregation.
    Hansen ML; Ambjørn M; Harndahl MN; Benned-Jensen T; Fog K; Bjerregaard-Andersen K; Sotty F
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson's disease.
    Ferrari E; Scheggia D; Zianni E; Italia M; Brumana M; Palazzolo L; Parravicini C; Pilotto A; Padovani A; Marcello E; Eberini I; Calabresi P; Diluca M; Gardoni F
    Pharmacol Res; 2022 Sep; 183():106375. PubMed ID: 35918045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polypeptides derived from α-Synuclein binding partners to prevent α-Synuclein fibrils interaction with and take-up by cells.
    Monsellier E; Bendifallah M; Redeker V; Melki R
    PLoS One; 2020; 15(8):e0237328. PubMed ID: 32790707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α-Synuclein Preformed Fibrils Bind to β-Neurexins and Impair β-Neurexin-Mediated Presynaptic Organization.
    Feller B; Fallon A; Luo W; Nguyen PT; Shlaifer I; Lee AK; Chofflet N; Yi N; Khaled H; Karkout S; Bourgault S; Durcan TM; Takahashi H
    Cells; 2023 Apr; 12(7):. PubMed ID: 37048156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carboxy-terminal truncations of mouse α-synuclein alter aggregation and prion-like seeding.
    Sorrentino ZA; Xia Y; Gorion KM; Hass E; Giasson BI
    FEBS Lett; 2020 Apr; 594(8):1271-1283. PubMed ID: 31912891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. α-Synuclein propagation leads to synaptic abnormalities in the cortex through microglial synapse phagocytosis.
    Pérez-Acuña D; Shin SJ; Rhee KH; Kim SJ; Lee SJ
    Mol Brain; 2023 Oct; 16(1):72. PubMed ID: 37848910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuronal activity modulates alpha-synuclein aggregation and spreading in organotypic brain slice cultures and in vivo.
    Wu Q; Shaikh MA; Meymand ES; Zhang B; Luk KC; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2020 Dec; 140(6):831-849. PubMed ID: 33021680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synaptic location is a determinant of the detrimental effects of α-synuclein pathology to glutamatergic transmission in the basolateral amygdala.
    Chen L; Nagaraja C; Daniels S; Fisk ZA; Dvorak R; Meyerdirk L; Steiner JA; Escobar Galvis ML; Henderson MX; Rousseaux MWC; Brundin P; Chu HY
    Elife; 2022 Jul; 11():. PubMed ID: 35775627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling α-Synucleinopathy in Organotypic Brain Slice Culture with Preformed α-Synuclein Amyloid Fibrils.
    Roux A; Wang X; Becker K; Ma J
    J Parkinsons Dis; 2020; 10(4):1397-1410. PubMed ID: 32716318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor Cortex.
    Boutros SW; Raber J; Unni VK
    J Parkinsons Dis; 2021; 11(3):1091-1115. PubMed ID: 34057097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of α-Synuclein Does Not Affect Mitochondrial Bioenergetics in Rodent Neurons.
    Pathak D; Berthet A; Bendor JT; Yu K; Sellnow RC; Orr AL; Nguyen MK; Edwards RH; Manfredsson FP; Nakamura K
    eNeuro; 2017; 4(2):. PubMed ID: 28462393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons.
    Froula JM; Henderson BW; Gonzalez JC; Vaden JH; Mclean JW; Wu Y; Banumurthy G; Overstreet-Wadiche L; Herskowitz JH; Volpicelli-Daley LA
    Acta Neuropathol Commun; 2018 May; 6(1):35. PubMed ID: 29716652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
    Schell H; Hasegawa T; Neumann M; Kahle PJ
    Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity.
    Sorrentino ZA; Brooks MMT; Hudson V; Rutherford NJ; Golde TE; Giasson BI; Chakrabarty P
    Mol Neurodegener; 2017 May; 12(1):40. PubMed ID: 28552073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α-Synuclein decoy peptide protects mice against α-synuclein-induced memory loss.
    Guo Q; Kawahata I; Jia W; Wang H; Cheng A; Yabuki Y; Shioda N; Fukunaga K
    CNS Neurosci Ther; 2023 Jun; 29(6):1547-1560. PubMed ID: 36786129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multiverse of α-synuclein: investigation of prion strain properties with carboxyl-terminal truncation specific antibodies in animal models.
    Lloyd GM; Quintin S; Sorrentino ZA; Gorion KM; Bell BM; Long B; Paterno G; Giasson BI
    Acta Neuropathol Commun; 2024 Jun; 12(1):91. PubMed ID: 38858742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excitatory synaptic structural abnormalities produced by templated aggregation of α-syn in the basolateral amygdala.
    Gcwensa NZ; Russell DL; Long KY; Brzozowski CF; Liu X; Gamble KL; Cowell RM; Volpicelli-Daley LA
    Neurobiol Dis; 2024 Sep; 199():106595. PubMed ID: 38972360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracerebroventricular injection of α-synuclein preformed fibrils do not induce motor and olfactory impairment in C57BL/6 mice.
    Mi X; Li M; Zhang Y; Qu L; Xu A; Xie J; Song N
    Neuroscience; 2024 Nov; 559():293-301. PubMed ID: 39251058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.